“…Localized lipoatrophy may be seen following connective tissue diseases, such as, lupus erythematosus, morphea, dermatomyositis, and overlap syndrome disease; neoplasms, such as T-cell lymphoma; drug injections, such as corticosteroids, benzathine penicillin, insulin, methotrexate, vasopressin, growth hormone, glatiramer acetate, copolymer 1, iron dextran, and DPT vaccine (drugs in order of reported frequency); or as primary idiopathic lipoatrophy. [1][2][3][5][6][7] Localized lipoatrophy may represent the end-stage of panniculitis in a localized expression of connective tissue disease. [8] Thus ANA, anti-ds-DNA, anti-Sm, and anti-U1-RNP immunoassay should be performed in all cases of localized lipoatrophy.…”